Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...
The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.
AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...
A new imaging technique reveals ribosomes work together when translating mRNA, preventing slowdowns in protein production. This discovery challenges prior beliefs and could revolutionize our ...
This important study reports single-nucleus multiomics-based profiling of transcriptome and chromatin accessibility of mouse XX and XY primordial germ cells (PGCs). The main conclusions of this study, ...
The IAEA's NUCLEUS information resource portal provides access to over 100 scientific, technical and regulatory resources, including databases, applications, publications and training material. As it ...
A 'pocket' on the protein cyclin B is responsible for ensuring that the steps of cell division take place in the correct order.
This study uses single nucleus multi-omics to profile the transcriptome and chromatin accessibility of mouse XX and XY primordial germ cells (PGCs) at three time points spanning PGC sexual ...
Jan. 31, 2025 — Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders -- T cells -- lose their ability to ...
Nucleus Software Exports Ltd. key Products/Revenue Segments include Software Products and Software Development Charges for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has ...
Following our stories about the state's best new restaurants and a local island named among the world's top travel destinations, the USA TODAY NETWORK-Florida Dining and Entertainment Team now ...
Obesity programs: <li /> Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide ...